We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$1.05B
AUM Growth
+$33.6M
Cap. Flow
-$31.6M
Cap. Flow %
-3.01%
Top 10 Hldgs %
44.38%
Holding
72
New
1
Increased
31
Reduced
24
Closed

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$11.7M
2
MANH icon
Manhattan Associates
MANH
+$4.44M
3
ICLR icon
Icon
ICLR
+$1.14M
4
SEIC icon
SEI Investments
SEIC
+$1.02M
5
TBRG
TruBridge
TBRG
+$937K

Sector Composition

Rank Sector Weight
1 Healthcare 39.03%
2 Technology 29%
3 Industrials 8.14%
4 Financials 7.97%
5 Consumer Discretionary 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MANH icon
1
Manhattan Associates
MANH
$11.4B
$80.1M 7.63%
1,343,475
-80,287
-6% -$4.44M
BHC icon
2
Bausch Health
BHC
$2.34B
$78.7M 7.5%
354,303
-52,800
-13% -$11.7M
ICLR icon
3
Icon
ICLR
$12.7B
$50.7M 4.83%
753,985
-16,900
-2% -$1.14M
CGNX icon
4
Cognex
CGNX
$11.3B
$41.8M 3.98%
1,735,950
-12,670
-0.7% -$311K
ILMN icon
5
Illumina
ILMN
$28.4B
$41M 3.9%
192,853
+129
+0.1% +$25.2K
HOLX
6
DELISTED
Hologic
HOLX
$38.2M 3.64%
1,003,635
-11,190
-1% -$392K
FDS icon
7
Factset
FDS
$10.2B
$36.7M 3.5%
226,040
-1,160
-0.5% -$188K
IDXX icon
8
Idexx Laboratories
IDXX
$46.2B
$34M 3.24%
530,136
+16,020
+3% +$1.11M
RMD icon
9
ResMed
RMD
$30.7B
$32.8M 3.12%
581,480
+12,350
+2% +$779K
LKQ icon
10
LKQ Corp
LKQ
$6.29B
$32M 3.05%
1,058,798
-16,602
-2% -$461K
SEIC icon
11
SEI Investments
SEIC
$12.6B
$31.7M 3.02%
646,880
-21,710
-3% -$1.02M
ZBRA icon
12
Zebra Technologies
ZBRA
$17.8B
$31M 2.95%
278,890
-6,860
-2% -$712K
GNTX icon
13
Gentex
GNTX
$5.07B
$30.4M 2.89%
1,850,280
+45,950
+3% +$803K
VRNT
14
DELISTED
Verint Systems
VRNT
$28.9M 2.75%
933,672
+53,787
+6% +$1.74M
HAE icon
15
Haemonetics
HAE
$4B
$27.8M 2.65%
673,116
-7,094
-1% -$299K
JKHY icon
16
Jack Henry & Associates
JKHY
$11.1B
$24.7M 2.35%
381,473
+3,088
+0.8% +$205K
NICE icon
17
Nice
NICE
$5.97B
$23.2M 2.21%
364,605
-6,340
-2% -$400K
HMSY
18
DELISTED
HMS Holdings Corp.
HMSY
$22.4M 2.14%
1,306,290
+116,880
+10% +$1.98M
CPHD
19
DELISTED
Cepheid Inc
CPHD
$20.9M 1.99%
342,430
-2,310
-0.7% -$132K
AMRI
20
DELISTED
Albany Molecular Research Inc
AMRI
$20.1M 1.91%
993,280
-4,010
-0.4% -$77.4K
MD icon
21
Pediatrix Medical
MD
$2.2B
$19.5M 1.86%
263,530
+4,200
+2% +$302K
ABCO
22
DELISTED
Advisory Board Co
ABCO
$16.6M 1.58%
303,355
+188,310
+164% +$9.71M
IPCM
23
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$16.5M 1.58%
298,715
-3,500
-1% -$178K
FORR icon
24
Forrester Research
FORR
$224M
$16M 1.53%
445,287
+15,597
+4% +$551K
MORN icon
25
Morningstar
MORN
$7.53B
$15M 1.43%
188,220
-3,930
-2% -$301K

Similar funds

American Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, American Capital Management held 72 positions worth $1.05B, up 3.3% from $1.02B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

American Capital Management withdrew a net $31.6M in Q2 2015, reducing 24 holdings. Its largest reduction was Bausch Health, cutting an estimated $11.7M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, American Capital Management opened a new position in PowerFleet Inc worth $177K.

  • American Capital Management's largest Q2 2015 buy was PowerFleet Inc: 29,000 shares worth $177K.
  • American Capital Management added most to Advisory Board Co in Q2 2015, an estimated $9.71M increase.
  • American Capital Management's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $11.7M.
  • American Capital Management's ten largest holdings make up 44% of its $1.05B portfolio in Q2 2015.
  • American Capital Management opened 1 new position and closed 0 in Q2 2015.
  • American Capital Management's portfolio value rose 3.3% quarter-over-quarter to $1.05B.

Based on American Capital Management's 13F filing for Q2 2015, filed 21 Jul 2015.